Constanze Pfitzer

Dr. Constanze Pfitzer


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2017 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
CPConstanze Pfitzer
Constanze Pfitzer
PHPaul C. Helm
Paul C. Helm
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
FBFelix Berger
Felix Berger
UBUlrike M. M. Bauer
Ulrike M. M. Bauer
KSKatharina Rl Schmitt
Katharina Rl Schmitt

18 July 2017 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
CPConstanze Pfitzer
Constanze Pfitzer
PHPaul Christian Helm
Paul Christian Helm
HFHannah Ferentzi
Hannah Ferentzi
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
UBUlrike M. M. Bauer
Ulrike M. M. Bauer
KSKatharina R. L. Schmitt
Katharina R. L. Schmitt
Objective To assess the prevalence of congenital heart disease (CHD) in Germany in relation to phenotypes, severity and gender. Design Cross‐sectional registry study. Setting We analyzed data from patients with CHD born between 1996 and 2015. Patients A total of 26 630 patients, registered with the NRCHD, were born between 1996 and 2015. 10 927 patients were excluded from the current analysis due to prior registration with the NRCHD under the German PAN Prevalence Study, which showed a potential bias in the inclusion of this patient population (proportion of mild cardiac lesions was comparatively high due to improved diagnostic capability for earlier identifying minor lesions). At least 15 703 patients with demographic data and detailed medical information were included in the current study. Interventions None. Outcome Measures Prevalence of CHD in Germany differentiated into gender, severity, and phenotype. Results In total, 15 703 patients with CHD (47.1% female) were included in this study. The five most common phenotypes were found to be ventricular septal defect (19.2%), atrial septal defect (13.0%), Tetralogy of Fallot (9.3%), univentricular heart (9.4%), and coractation of the aortae (7.0%). The prevalence of CHD in regard to severity changed over the duration of the observation period. From 1996 to 2007, the number of simple CHD rose steadily (P < .001), whereas the number of severe CHD has grown significantly since 2008/2009 (P < .001). In regard to gender, the prevalence of simple CHD was higher in females, whereas complex lesions were more common in males (P < .001). Conclusions Our study shows a growing number of registered severe CHD in the recent decade in Germany. This development is noteworthy as it implicates a growing demand for first intensive hospital care, expert pediatric cardiologic aftercare, and consequently higher economic impact for this patient population.

13 September 2017 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
CPConstanze Pfitzer
Constanze Pfitzer
PHPaul C. Helm
Paul C. Helm
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
CWChristoph Walker
Christoph Walker
HFHannah Ferentzi
Hannah Ferentzi
KSKatharina R. L. Schmitt
Katharina R. L. Schmitt
Purpose: Through this study we aimed to assess the educational level and employment status of adults with CHD in Germany.Methods: Data were acquired from an online survey carried out in 2015 by the German National Register for Congenital Heart Defects. A total of 1458 adults with CHD participated in the survey (response rate: 37.6%). For 1198 participants, detailed medical information, such as main cardiac diagnosis and information from medical reports, was available.Results: Of the participants surveyed (n=1198), 54.5% (n=653) were female, and the mean age was 30 years. The majority of respondents (59.4%) stated that they had high education levels and that they were currently employed (51.1%). Patients with simple CHD had significantly higher levels of education (p<0.001) and were more likely to be employed (p=0.01) than were patients with complex CHD.Conclusions: More than half of the participants had high education levels and the majority were employed. The association between CHD and its severity and individuals’ educational attainment should be investigated more closely in future studies.

1 May 2017 in Hypoxia
Verified
Journal Article
Open access
PDF file
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
GTGiang Tong
Giang Tong
CWChristoph Walker
Christoph Walker
SWSylvia J Wowro
Sylvia J Wowro
JKJana Krech
Jana Krech
KSKatharina Rose Luise Schmitt
Katharina Rose Luise Schmitt
Objective: Therapeutic hypothermia is an established treatment for perinatal asphyxia. Yet, many term infants continue to die or suffer from neurodevelopmental disability. Several experimental studies have demonstrated a beneficial effect of mild-to-moderate hypothermia after hypoxic injury, but the understanding of hypothermia-induced neuroprotection remains incomplete. In general, global protein synthesis is attenuated by hypothermia, but a small group of RNA-binding proteins including the RNA-binding motif 3 (RBM3) is upregulated in response to cooling. The aim of this study was to establish an in vitro model to investigate the effects of hypoxia and hypothermia on neuronal cell survival, as well as to examine the kinetics of concurrent cold-shock protein RBM3 gene expression. Methods: Experiments were performed by using human SK-N-SH neurons exposed to different oxygen concentrations (21%, 8%, or 0.2% O2) for 24 hours followed by moderate hypothermia (33.5°C) or normothermia for 24, 48, or 72 hours. Cell death was determined by quantification of lactate dehydrogenase and neuron-specific enolase releases into the cell cultured medium, and cell morphology was assessed by using immunofluorescence staining. The regulation of RBM3 gene expression was assessed by reverse transcriptase-quantitative polymerase chain reaction and Western blot analysis. Results: Exposure to hypoxia (0.2% O2) for 24 hours resulted in significantly increased cell death in SK-N-SH neurons, whereas exposure to 8% O2 had no significant impact on cell viability. Post-hypoxia treatment with moderate hypothermia for 48 or 72 hours rescued the neurons from hypoxia-induced cell death. Moreover, exposure to severe hypoxia led to observable cell swelling, which was also attenuated by moderate hypothermia. Finally, moderate hypothermia but not hypoxia led to the induction of RBM3 expression on both transcriptional and translational levels. Conclusion: Moderate hypothermia protects neurons from hypoxia-induced cell death. The expression of the cold-shock protein RBM3 is induced by moderate hypothermia and could be one possible mediator of hypothermia-induced neuroprotection.

1 January 2019 in Early Human Development
Verified
Journal Article
Closed access
CPConstanze Pfitzer
Constanze Pfitzer
PHPaul C. Helm
Paul C. Helm
MBMaximilian J. Blickle
Maximilian J. Blickle
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
FBFelix Berger
Felix Berger
KSKatharina R.L. Schmitt
Katharina R.L. Schmitt

1 November 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
CPConstanze Pfitzer
Constanze Pfitzer
LBLisa Aleksandra Buchdunger
Lisa Aleksandra Buchdunger
PHPaul C. Helm
Paul C. Helm
MBMaximilian J. Blickle
Maximilian J. Blickle
LRLisa-Maria Rosenthal
Lisa-Maria Rosenthal
KSKatharina R.L. Schmitt
Katharina R.L. Schmitt